CADL
Price
$6.74
Change
-$0.18 (-2.60%)
Updated
Jul 18 closing price
Capitalization
337.69M
45 days until earnings call
INKT
Price
$20.31
Change
-$2.94 (-12.65%)
Updated
Jul 18 closing price
Capitalization
80.95M
Interact to see
Advertisement

CADL vs INKT

Header iconCADL vs INKT Comparison
Open Charts CADL vs INKTBanner chart's image
Candel Therapeutics
Price$6.74
Change-$0.18 (-2.60%)
Volume$714.48K
Capitalization337.69M
MiNK Therapeutics
Price$20.31
Change-$2.94 (-12.65%)
Volume$683.19K
Capitalization80.95M
CADL vs INKT Comparison Chart in %
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. INKT commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and INKT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (CADL: $6.74 vs. INKT: $20.31)
Brand notoriety: CADL and INKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 72% vs. INKT: 53%
Market capitalization -- CADL: $337.69M vs. INKT: $80.95M
CADL [@Biotechnology] is valued at $337.69M. INKT’s [@Biotechnology] market capitalization is $80.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileINKT’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • INKT’s FA Score: 0 green, 5 red.
According to our system of comparison, INKT is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 5 TA indicator(s) are bullish while INKT’s TA Score has 8 bullish TA indicator(s).

  • CADL’s TA Score: 5 bullish, 4 bearish.
  • INKT’s TA Score: 8 bullish, 3 bearish.
According to our system of comparison, INKT is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +16.01% price change this week, while INKT (@Biotechnology) price change was -68.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CADL is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($338M) has a higher market cap than INKT($80.9M). INKT YTD gains are higher at: 191.433 vs. CADL (-22.350). INKT has higher annual earnings (EBITDA): -9.14M vs. CADL (-36.84M). CADL has more cash in the bank: 92.2M vs. INKT (3.24M). INKT has less debt than CADL: INKT (5.12M) vs CADL (10.9M). CADL (0) and INKT (0) have equivalent revenues.
CADLINKTCADL / INKT
Capitalization338M80.9M418%
EBITDA-36.84M-9.14M403%
Gain YTD-22.350191.433-12%
P/E RatioN/AN/A-
Revenue00-
Total Cash92.2M3.24M2,850%
Total Debt10.9M5.12M213%
TECHNICAL ANALYSIS
Technical Analysis
CADLINKT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 24 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LGDTF0.240.01
+2.98%
Liberty Gold Corp
QUILF2.21N/A
N/A
Quilter PLC
STJPF16.10N/A
N/A
St. James Place Capital Plc.
GRCMF0.02N/A
N/A
GREEN SHIFT COMMODITIES LTD.
MITSY401.59-1.55
-0.38%
Mitsui & Co., Ltd.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RPTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-2.60%
RPTX - CADL
43%
Loosely correlated
-0.66%
CCCC - CADL
34%
Loosely correlated
+6.42%
XERS - CADL
34%
Loosely correlated
-2.29%
INKT - CADL
34%
Loosely correlated
-12.65%
INO - CADL
33%
Poorly correlated
N/A
More

INKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, INKT has been loosely correlated with RAIN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INKT jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INKT
1D Price
Change %
INKT100%
-12.65%
RAIN - INKT
44%
Loosely correlated
+7.44%
LPTX - INKT
42%
Loosely correlated
+0.88%
HYPD - INKT
34%
Loosely correlated
N/A
CADL - INKT
34%
Loosely correlated
-2.60%
PHVS - INKT
34%
Loosely correlated
-2.04%
More